ATE254455T1 - Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel - Google Patents

Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Info

Publication number
ATE254455T1
ATE254455T1 AT99951559T AT99951559T ATE254455T1 AT E254455 T1 ATE254455 T1 AT E254455T1 AT 99951559 T AT99951559 T AT 99951559T AT 99951559 T AT99951559 T AT 99951559T AT E254455 T1 ATE254455 T1 AT E254455T1
Authority
AT
Austria
Prior art keywords
water
mixable
pharmaceutical compositions
compositions containing
containing paclitaxel
Prior art date
Application number
AT99951559T
Other languages
English (en)
Inventor
Joseph Rubinfeld
Rajashree Joshi
Ashok Y Gore
Rajesh Shrotriya
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Application granted granted Critical
Publication of ATE254455T1 publication Critical patent/ATE254455T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99951559T 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel ATE254455T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/183,199 US6017948A (en) 1998-10-30 1998-10-30 Water-miscible pharmaceutical compositions
PCT/US1999/021990 WO2000025775A1 (en) 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel

Publications (1)

Publication Number Publication Date
ATE254455T1 true ATE254455T1 (de) 2003-12-15

Family

ID=22671864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951559T ATE254455T1 (de) 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Country Status (11)

Country Link
US (1) US6017948A (de)
EP (1) EP1124549B1 (de)
JP (1) JP2002528494A (de)
CN (1) CN1178655C (de)
AT (1) ATE254455T1 (de)
AU (1) AU775158B2 (de)
CA (1) CA2345697A1 (de)
DE (1) DE69912983D1 (de)
IL (1) IL142720A (de)
MX (1) MXPA01004268A (de)
WO (1) WO2000025775A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US6136846A (en) 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE60220519T2 (de) 2001-04-20 2007-09-27 The University Of British Columbia, Vancouver Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
US20030126788A1 (en) * 2001-11-07 2003-07-10 Colloid Tech. Inc. Storage stable translucent flammable article
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
PL368945A1 (en) * 2001-11-30 2005-04-04 Bristol-Myers Squibb Company Paclitaxel solvates
ATE424187T1 (de) * 2002-07-15 2009-03-15 Alcon Inc Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
EP1896040B1 (de) 2005-06-29 2012-08-01 Threshold Pharmaceuticals, Inc. Phosphoramidat-alkylator-prodrugs
US9943490B2 (en) 2007-11-05 2018-04-17 The Trustees Of Princeton University Composite flash-precipitated nanoparticles
WO2009087678A2 (en) * 2007-12-24 2009-07-16 Sun Pharma Advanced Research Company Limited Nanodispersion
EP2350664B1 (de) * 2008-10-21 2021-05-19 ImmunoGenesis, Inc. Behandlung von krebs anhand vom hypoxie-aktivierten promedikament th-302 in kombinatin mit docetaxel oder pemetrexed
EP2442805A4 (de) 2009-06-19 2012-11-21 Sun Pharma Advanced Res Co Ltd Nanodispersion aus einem medikament und verfahren zu ihrer herstellung
US10842770B2 (en) 2010-05-03 2020-11-24 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2012092421A2 (en) * 2010-12-30 2012-07-05 Surmodics, Inc. Composition for intravascular delivery of therapeutic composition
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN112972419B (zh) * 2019-12-02 2024-03-08 四川科伦药物研究院有限公司 一种白蛋白纳米药物组合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5034397A (en) * 1985-12-12 1991-07-23 Bristol-Myers Squibb Co. Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
AU630469B2 (en) * 1989-05-26 1992-10-29 Abbott Laboratories Injectable clarithromycin composition
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
ES2128761T3 (es) * 1994-09-01 1999-05-16 Upjohn Co Formulacion de tirilazad con cosolvente para administracion parenteral.
AU4652596A (en) * 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
EP0868183B1 (de) * 1995-12-21 2002-01-30 Pfizer Inc. Injizierbare quinolonformulierungen
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel

Also Published As

Publication number Publication date
AU6397799A (en) 2000-05-22
EP1124549A1 (de) 2001-08-22
IL142720A (en) 2005-03-20
DE69912983D1 (de) 2003-12-24
MXPA01004268A (es) 2002-06-04
EP1124549B1 (de) 2003-11-19
CA2345697A1 (en) 2000-05-11
AU775158B2 (en) 2004-07-22
US6017948A (en) 2000-01-25
CN1178655C (zh) 2004-12-08
WO2000025775A1 (en) 2000-05-11
JP2002528494A (ja) 2002-09-03
CN1368880A (zh) 2002-09-11
IL142720A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
ATE254455T1 (de) Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel
DE50004352D1 (de) Farbmittelzubereitungen
BR0215405A (pt) Composições e processos de uso de collajolie
ITRM20020411A0 (it) Derivati dello spirobifluorene, loro preparazione e loro uso.
BR9915515B1 (pt) composiÇço curÁvel de multicomponentes.
WO2004045001A3 (en) Organic light emitting materials and devices
AU2001274078A1 (en) Prepolymeric (meth)acrylates with polycyclic or aromatic segments
NO20003930L (no) Sammensetninger som inneholder organiske forbindelser
BR0300500B1 (pt) composiÇço poliolefÍnica, processo para estabilizaÇço de uma poliolefina e uso de uma mistura.
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
NO20032252D0 (no) Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor
DE59903442D1 (de) Azidfreie, gaserzeugende Zusammensetzung
WO2001087824A3 (en) 7-substituted fused ring tetracycline compounds
EA199900373A2 (ru) Фармацевтические композиции
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
BR0317593A (pt) Formas de dosagem compreendendo um inibidor de cetp e um inibidor de hmg-coa reductase
AR028162A1 (es) Disponibilidad controlada de compuestos de formulacion, composiciones y metodos para el lavado que utilizan los mismos.
NO20031648L (no) Farmasöytiske lösninger av modafinilforbindelser
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
PA8577701A1 (es) Polipeptido t20 pegilado
ATE441626T1 (de) Azeotropähnliche zusammensetzungen und deren verwendung
ID21353A (id) Senyawa bi-aromatik yang terikat melalui radikal heteroetilena, serta komposisi farmasi dan kosmetik yang mengandungnya
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties